Adjuvant chemotherapy is not associated with improved survival for all high-risk factors in stage II colon cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adjuvant chemotherapy is not associated with improved survival for all high-risk factors in stage II colon cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 139, Issue 1, Pages 187-193
Publisher
Wiley
Online
2016-02-26
DOI
10.1002/ijc.30053
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases
- (2015) Lydia G. M. van der Geest et al. CLINICAL & EXPERIMENTAL METASTASIS
- Predictors of disease-free survival in colorectal cancer with microsatellite instability: An AGEO multicentre study
- (2015) D. Tougeron et al. EUROPEAN JOURNAL OF CANCER
- Effects of adjuvant chemotherapy on recurrence, survival, and quality of life in stage II colon cancer patients: a 24-month follow-up
- (2015) Cari Lewis et al. SUPPORTIVE CARE IN CANCER
- A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer
- (2014) Elinor Bexe Lindskog et al. BMC CANCER
- The COLON study: Colorectal cancer: Longitudinal, Observational study on Nutritional and lifestyle factors that may influence colorectal tumour recurrence, survival and quality of life
- (2014) Renate M Winkels et al. BMC CANCER
- Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer
- (2014) Aalok Kumar et al. CANCER
- Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factor
- (2014) Niek Hugen et al. INTERNATIONAL JOURNAL OF CANCER
- Metachronous metastases from colorectal cancer: a population-based study in North-East Netherlands
- (2014) Marloes A. G. Elferink et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Prognosis and value of adjuvant chemotherapy in stage III mucinous colorectal carcinoma
- (2013) N. Hugen et al. ANNALS OF ONCOLOGY
- Identification of Risk Factors for Recurrence in High-Risk Stage II Colon Cancer
- (2013) Satoshi Hatano et al. INTERNATIONAL SURGERY
- Molecular Pathways: Microsatellite Instability in Colorectal Cancer: Prognostic, Predictive, and Therapeutic Implications
- (2012) F. A. Sinicrope et al. CLINICAL CANCER RESEARCH
- Clinicopathological risk factors of Stage II colon cancer: results of a prospective study
- (2012) C. Santos et al. Colorectal Disease
- Effect of Adjuvant Chemotherapy on Survival of Patients With Stage III Colon Cancer Diagnosed After Age 75 Years
- (2012) Hanna K. Sanoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Chemotherapy for Stage II Colon Cancer With Poor Prognostic Features
- (2011) Erin S. O'Connor et al. JOURNAL OF CLINICAL ONCOLOGY
- Large age and hospital-dependent variation in administration of adjuvant chemotherapy for stage III colon cancer in southern Netherlands
- (2009) L. N. van Steenbergen et al. ANNALS OF ONCOLOGY
- Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
- (2009) Thierry André et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More